Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial

• Xue Chen,
• Xiuping Han,
• Bo Cheng,
• Hui Li,
• Lingling Liu,
• Songmei Geng,
• Linfeng Li,
• Jie Li,
• Qing Guo,
• Guoyi Zhang,
• Hong Fang,
• Jianzhong Zhang,
• Lishao Guo

Affiliations

Xue Chen

1 Department of Dermatology, Peking University People’s Hospital, Beijing 100044, China

Xiuping Han

2 Department of Dermatology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110055, China

Bo Cheng

3 Department of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350004, China

Hui Li

4 Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China

Lingling Liu

5 Department of Dermatology, Peking University First Hospital, Beijing 100034, China

Songmei Geng

6 Department of Dermatology, The Second Affiliated Hospital of Xi’an Jiaotong University (Xibei Hospital), Xi’an, Shaanxi 710006, China

Linfeng Li

7 Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China

Jie Li

8 Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China

Qing Guo

9 Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China

Guoyi Zhang

10 Department of Dermatology, Hospital for Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, Jiangsu 210042, China

Hong Fang

11 Department of Dermatology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China

Jianzhong Zhang

1 Department of Dermatology, Peking University People’s Hospital, Beijing 100044, China

Lishao Guo